Title of Invention


Abstract A cosmetic water-in-oil composition is provided which includes a water-in-oil emulsifying silicone surfactant, an ultrafine titanium dioxide and conjugated linoleic acid. The presence of conjugated linoleic acid stabilizes the composition against color degradation and also maintains an approximately steady viscosity.
Full Text J6994/C
FORM - 2
(39 of 1970)
The Patents Rules, 2003
(See Section 10 and Rule 13)

HINDUSTAN UNILEVER LIMITED, a company incorporated under the Indian Companies Act, 1913 and having its registered office at Hindustan Lever House, 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India

The following specification particularly describes the invention and the manner in which it is to be performed

WO 2007/073909 PCT/EP2006/012248
5 The invention concerns cosmetic emulsion compositions formulated with inorganic sunscreens stabilized against color and viscosity degradation.
Sunscreen compositions are commonly used during outdoor work or leisure. They protect exposed skin against sunburn, cancer and even photoaging. In general sunscreen 10 preparations are formulated as creams, lotions or oils containing as active agent an ultraviolet radiation absorbing or at least reflecting chemical compound.
The ideal sunscreen formulation should be non-toxic, non-irritating to skin tissue and capable of convenient application in a uniform continuous film. The sunscreen active agent as well as the 15 composition into which it is formulated should be sufficiently chemically and physically stable. An acceptable shelf life is required for extended storage.
Chromophoric organic sunscreen agents are generally the most effective. Unfortunately many of these organic actives cause adverse allergic reactions. It is therefore desirable to minimize 20 the level of such materials.
Inorganic ultrafine particulate compounds such as zinc oxide and titanium dioxide have been employed as sunscreen agents. Illustrations of this technology are found in US 5 215 749 and US 5 188 831, both to Nicoll et al. Inorganics are not known as sensitizers generating allergic 25 reactions. However the stability of such formulations is a noticeable problem. Adverse effects include viscosity builup and discoloration under extended storage conditions. These adverse consequences can be particulariy pronounced in emulsions which are of the oil continuous variety.
30 Accordingly there remains a need to uncover inorganic sunscreen particulate containing formulations of increased storage stability, particularly compositions resistant to significant changes in viscosity and color.
35 A cosmetic composition is provided which is a water-in-oil emulsion including:
(i) from about 0.1 to about 30% by weight of a water-in-oil emulsifying silicone surfactant; (ii) from about 0.1 to about 30% by weight of a titanium dioxide sunscreen
agent; and (iii) from about 0.1 to about 10% of a conjugated iinoleic acid.

WO 2007/073909



Now it has been found that a water-in-oil cosmetic composition containing conjugated linoieic acid can impart both viscosity and color stability to formulations containing sunscreen grade 5 titanium dioxide particulates. Ordinarily unsaturated compounds, of which CLA is an example, would themselves be expected to be unstable and color body producing. It was therefore surprising to note that CLA had the exact opposite effect in oil continuous emulsions that suspended titanium dioxide. Only small amounts of CLA were needed to achieve the stabilization results.
Conjugated Linoieic Acid
Conjugated linoieic acid (hereinafter referred to also as CLA) comprises a group of positional and geometric isomers of linoieic acid in which various configurations of cis and trans double bonds at positions (6,8), (7,9), (8,10), (9,11), (10,12) or (11,13) are possible. Thus twenty-four
15 different isomers of CLA exist
The invention also includes derivatives of the free acid which thus comprise conjugated linoieic acid moieties. Preferable derivatives include those derived from substitution of the carboxyl group of the acid, such as esters (e.g. retinyl esters, triglyceride esters, monoglyceride esters, 20 diglyceride esters, phosphoesters), amides (e.g. ceramide derivatives), salts (e.g. alkali meta! and alkali earth metal salts, ammonium salts), and/or those derived from substitution of the C18 carbon chain, such as alpha hydroxy and/or beta hydroxy derivatives.
In the case of triglyceride ester derivatives, all positional isomers of CLA substituents on the 25 glycerol backbone are included. The triglycerides must contain at least one CLA moiety. For example, of the three esterffiable positions on the glycerol backbone, the 1 and 2 positions may be esterified with CLA and by another lipid at position 3 or as an alternative, the glycerol backbone could be esterified by CLA at the 1 and 3 positions with another lipid at position 2.
30 Wherever the term "conjugated linoieic acid or "CLA" is used in this specification it is to be understood that the derivatives thereof comprising CLA moieties are also included. CLA moieties" refers to CLA fatty acyl portion(s) of a CLA derivative.
The isomers of greatest interest in the present cosmetic compositions are cis 9, trans 1 llinoleic 35 add and trans 10, cis12 linoieic acid. Hereinafter the term "9,11-linoIeic acid" or "10,12-linoleic acid" shall mean preferentially these two main isomers, but will include lesser amounts of the remaining isomers, particularly when obtained or derived from a natural source.

WO 2007/073909


3 In accordance with the present invention, 9,11 linoleic acid and 10,12 finoleic acid are formulated into cosmetic preparations either as the free acid, as individual chemical derivatives, or as combinations of free acid and derivative.
5 By "c9, t11 and t10, c12 isomer enriched CLA" is meant that at least 30% by weight of the total CLA (and/or CLA moieties) present in the composition is in the form of the cis 9, trans 11 and trans 10, cis 12 isomers. Preferably, at least 40%, most preferably at least 50%, by weight of the total CLA and/or CLA moieties present in the composition, is in the form of the aforementioned isomers. 10
The amount of the CLA present in emulsions of this invention may range from about 0.1 to about 10% by weight of the composition. More preferably the amount is from about 0.5% to about 5%, and most preferably from about 1% to about 3%.
15 Mixed isomers of CLA are prepared by high temperature alkali treatment of safflower oil, generating CLA with equal amounts of the c9, t11 and t10, d2 CLA Isomers. CLA enriched in the c9, t11 CLA is separated from the mix by selective esterification with lauryi alcohol using Geotrichum Candidum as a catalyst The enriched c9, t11 CLA is hydrolyzed and converted to the triglyceride. After the esterification step and separation the remaining CLA free acids are
20 enriched in t10, c12 CLA.
Commercially CLA is available as Clarinol® A-80 and A-95 from Loders-Croklaan, Channahon, Illinois and Neobee® CLA 80 and 90 from Stepan, North Field, Illinois.
25 Water-in-oil Surfactant
A wide variety of silicone surfactants are useful herein. These silicones are typically organically modified organopolysiloxanes such as dimethicone copolyols.
Non-limiting examples of dimethicone copolyols and other silicone surfactants useful herein 30 include polydimethylsiloxane polyether copolymers with pendant polyethylene oxide side chains, polydimethylsiloxane polyether copolymers with pendant polypropylene oxide side chains, polydimethylsiloxane polyether copolymers with pendant mixed polyethylene oxide and polypropylene oxide side chains, polydimethylsiloxane polyether copolymers with pendant mixed poiy(ethylene)(propy!ene)oxide side chains, polydimethylsiloxane polyether copolymers 35 with pendant organobetaine side chains, polydimethylsiloxane polyether copolymers with pendant carboxylate side chains, polydimethylsiloxane poryether copolymers with pendant quaternary ammonium side chains; and also further modifications of the preceding copolymers containing pendant C2-30 straight, branched, or cyclic alkyl moieties. Examples of commercially available dimethicone copolyols useful herein sold by Dow Coming Corporation are Dow

WO 2007/073909


4 Coming® 190,193, Q2-5220, 2501 Wax, 2-5324 fluid and 3225C (this latter material being sold as a mixture with cyclomethicone). Cetyl dimethicone copofyol is commercially available as a mixture with poIyglyceryl-4 isostearate and hexyl laurate and is sold under the tradename Abil® WE-09 (available from Goldschmidt). Cetyl dimethicone copolyol is also commercially available 5 as a mixture with hexyl laurate and polyglyceryl-3 oleate sold under the tradename Abil® WS-08 (also available from Goldschmidt). Other non-limiting examples of dimethicone copolyols include lauryl dimethicone copolyol, dimethicone copolyol acetate, dimethicone copolyol adipate, dimethicone copoiyolamine, dimethicone copolyol behenate, dimethicone copolyol butyl ether, dimethicone copolyol hydroxy stearate, dimethicone copolyol isostearate, 10 dimethicone copoiyol laurate, dimethicone copolyol methyl ether, dimethicone copolyol phosphate, dimethicone copolyol sulfosuccinate and dimethicone copolyol stearate. Most preferred is PEG-10 Dimethicone available from Shin-Etsu.
Amounts of the silicone surfactant may range from about 0.1 to about 30%, preferably from 15 about 1 to about 10%, optimally from about 1.5 to about 5% by weight of the composition.
Titanium Dioxide Particles
Compositions of this invention will contain uttrafine titanium dioxide in a form which may either be a water-dispersible or an oil-dispersible form. By a "ultrafine titanium dioxide" is meant 20 titanium dioxide having an average particle size of less than 100 nm, preferably from about 90 to about 1 nm, more preferably from about 60 to about 5 nm, even more preferably from about 30 to about 10 nm, and optimally from about 25 to about 15 nm.
Water-dispersible titanium dioxide is an ultrafine titanium dioxide the particles of which are 25 uncoated or which are coated with a material to impart a hydrophilic surface property to the particles. Examples of such materials include aluminum oxide, silica and aluminum silicate.
Oil-dispersible titanium dioxide is ultrafine titanium dioxide, the particles of which exhibit a hydrophobic surface property, and which for this purpose can be coated with hydrophobic
30 materials including metal soaps such as aluminum stearate, aluminum laurate or zinc stearate, or with organosilicone compounds such as dimethicones and dimethiconols. Other useful coatings include polyols such as butylenes glycol, polyethylene glycol and glycerin; natural and synthetic esters including castor oil, caprylic/capric triglyceride, octyl dodecyl neopentanoate, isopropyl myristate, octyl palmitate, alkyl benzoate and mixtures thereof; and
35 combinations of organic liquids with inorganic powders. Most preferred are the oil-dispersible titanium dioxides.

WO 2007/073909 PCT/EP2006/012248
Amounts of the titanium dioxide sunscreen agent may range from about 0.1 to about 30%, preferably from about 0.5 to about 15%, more preferably from about 1 to about 10% by weight of the composition.
5 Dispersed Aqueous Phase
The compositions of the presert invention comprise from abou\ 5% \o about 90%, more preferably from about 30% to about 75%, and even more preferably from about 45% to about 60% of a dispersed aqueous phase. In emulsion technology, the term "dispersed phase" means that the phase exists as small particles or droplets suspended in and surrounded by a 10 continuous phase. The dispersed phase is also known as the internal or discontinuous phase. The dispersed aqueous phase is a dispersion of small aqueous particles or droplets suspended in and surrounded by the continuous silicone phase described hereinbefore.
The aqueous phase can be water, or a combination of water and one or more water soluble or 15 dispersible ingredients. Non-limiting examples of such optional ingredients include thickeners, acids, bases, salts, chelants, gums, water-soluble or dispersible alcohols and polyols, buffers, preservatives and colorants.
Optional Components 20 The composition of the present invention may contain a variety of other ingredients that are conventionally used in given product types provided that they do not unacceptably alter the benefits for the invention.
A component of the present invention may be a crosslinked silicone (organopolysiloxane) 25 elastomer. No specific restriction exists as to the type of curable organopolysiloxane composition that can serve as starting material for the crosslinked silicone elastomer. Examples in this respect are addition reaction-curing organopolysiloxane compositions which cure under platinum metal catalysis by the addition reaction between SiH-containing diorganopolysiloxane and organopolysiloxane having silicon-bonded vinyl groups; 30 condensation-curing organopolysiloxane compositions which cure in the presence of an organotin compound by a dehydrogenation reaction between hydroxy! terminated diorganopolysiloxane and SiH-containing diorganopolysiloxane; condensation-curing organopolysiloxane compositions which cure in the presence of an organotin compound or a titanate ester, by a condensation reaction between a hydroxy! terminated diorganopolysiloxane 35 and a hydrolyzable organosilane (this condensation reaction is exemplified by dehydration, alcohol-liberating, oxime-liberating, amine-Iiberating, amide-liberating, carboxyHiberating and ketone-liberating reactions); peroxide-curing organopolysiloxane compositions which thermally cure in the presence of an organoperoxide catalyst, and organopolysiloxane compositions

WO 2007/073909


6 which are cured by high-energy radiation, such as by gamma-rays, ultraviolet radiation, or electron beams.
Addition reaction-curing organopolysiloxane compositions are preferred for their rapid curing 5 rates and excellent uniformity of curing. A particularly preferred addition reaction-curing organopolysiloxane composition is prepared from:
an organopolysiloxane having at least 2 lower alkenyl groups in each molecule; an organopolysiloxane having at least 2 silicon-bonded hydrogen atoms in each molecule; and a platinum-type catalyst
The crosslinked siloxane elastomer may either be an emulsifying or non-emulsifying crosslinked organopolysiloxane elastomer or combinations thereof. The term "non-emulsifying," as used herein, defines crosslinked organopolysiloxane elastomer from which polyoxyalkylene units are absent. The term "emulsifying," as used herein, means crosslinked
15 organopolysiloxane elastomer having at least one polyoxyalkylene (e.g. polyoxyethylene or pofyoxypropylene) unit.
Particularly useful emulsifying elastomers are polyoxyalkylene-modified elastomers formed from divinyl compounds, particularly siloxane polymers with at least two free vinyl groups, 20 reacting with Si-H linkages on a polysiloxane backbone. Preferably the elastomers are dimethyl polysiloxanes crosslinked by Si-H sites on a moieculariy spherical MQ resin.
Preferred silicone elastomers are organopolysiloxane compositions available under the INCI names of dimethicone/vinyl dimethicone crosspolymer, dimethicone crosspolymer and 25 Polysilicone-11. Ordinarily these materials are provided as a 1-30% crosslinked silicone elastomer dissolved or suspended in a dimethicone fluid (usually cydomethicone). For purposes of definition "crosslinked silicone elastomer" refers to the elastomer alone rather than the total commercial compositions which also include a solvent (eg. dimethicone) earner.
30 Dimethicone/vinyl dimethicone crosspolymers and dimethicone crosspolymers are available from a variety of suppliers including Dow Coming (9040, 9041, 9045, 9506 and 9509), General Electric (SFE 839), Shin-Etsu (KSG-15, 16, 18 [dimethicone/phenyl vinyl dimethicone crosspolymer]), and Grant Industries (Gransil™ line of materials), and lauryl dimethiconeArinyl dimethicone crosspolymers supplied by Shin-Etsu (e.g. KSG-31, KSG-32, KSG-41, KSG-42,
35 KSG-43 and KSG-44).
Other suitable commercially available silicone elastomer powders include vinyl dimethicone/methicone silesquioxane crosspolymers from Shin-Etsu sold as KSP-100, KSP-101, KSP-102, KSP-103, KSP-104, KSP-105, and hybrid silicone powders that contain a

WO 2007/073909 PCT/EP2006/012248
fluoroalkyl group or a phenyl group sold by Shin-Etsu as respectively KSP-200 and KSP-300. Also of use is Dow Coming 5-7070, a silicone amino elastomer emulsion with INCI name of silicone quatemium-16/glycidoxy dimethicone crosspolymer (and) trideceth-12.
5 The crosslinked silicone elastomers may range in concentration from about 0.01 to about 30%, preferably from about 0.1 to about 10%, optimally from about 0.5 to about 2% by weight of the cosmetic composition. These weight values exclude any solvent such as cyclomethicone found in commercial "elastomer" silicones such as the Dow Coming products 9040 and 9045. For instance, the amount of crosslinked silicone elastomer in 9040 and 9045 is between 12 and 10 13% by weight
Most preferred as the silicone elastomer is DC 9045 which has a D5 cyclomethicone swelled elastomer particle size (based on volume and calculated as spherical particles) which averages about 38 micron, and may range from about 25 to about 55 micron.
The compositions may include from about 1 % to about 80%, by weight of the composition, of a suitable earner for the crosslinked organopolysiloxane elastomer component described above. The carrier, when combined with the cross-linked organopolysiloxane elastomer particles serves to suspend and swell the elastomer particles to provide an elastic, gel-like network or
20 matrix. The carrier for the crosslinked siloxane elastomer is liquid under ambient conditions, and preferably has a low viscosity to provide for improved spreading on the skin.
Concentrations of the earner may range from about 5% to about 60%, more preferably from about 5% to about 40%, by weight of the composition.
These liquid carriers may be organic, silicone-containing or fluorine-containing, volatile or non¬volatile, polar or non-polar, provided that the liquid carrier forms a solution or other homogeneous liquid or liquid dispersion with the selected cross-linked siloxane elastomer at the selected siloxane elastomer concentration at a temperature of from about 28°C to about 250°C,
30 preferably from about 28°C to about 78°C. The term "non-polar" typically means that the material has a solubility parameter below about 6.5 (calfan3)05.
The non-polar, volatile oil tends to impart highly desirable aesthetic properties to the compositions of the present invention. Consequently, the non-polar, volatile oils are preferably 35 utilized at a fairly high level. Non-polar, volatile oils particularly useful in the present invention are silicone oils; hydrocarbons; and mixtures thereof. Examples of preferred non-polar, volatile hydrocarbons include polydecanes such as isododecane and isodecane (e.g., Permethyl-99A which is available from Presperse Inc.) and the c7-8 through C12.15 isoparaffins (such as the Isopar Series available from Exxon Chemicals). Particularty preferred volatile silicone oils are

WO 2007/073909


8 cyclic volatile silicones wherein the repeating unit ranges from about 3 to about 5; and linear silicones wherein the repeating unit ranges from about 1 to about 7. Highly preferred examples of volatile silicone oils include cyclomethicones of varying viscosities, e.g. Dow Coming 200, Dow Coming 244, Dow Coming 245, Dow Coming 344 and Dow Coming 345, (commercially 5 available from Dow Coming Corp.); SF-1204 and SF-1202 Silicone Fluids, GE 7207 and 7158 (commercially available from G.E. Silicones) and SWS-03314 {commerciany available from SWS Silicones Corp).
Compositions of the present invention may also contain C1-20 alpha- and beta- hydroxy 10 carboxylic acids and salts thereof. The salts are preferably alkaline metal, ammonium and O.12 alkanolammonium salts and mixtures thereof. The term "alpha-hydroxycarboxylic acids" includes not only hydroxy acids but also alpha- ketoacids and related compounds of polymeric forms of hydroxyacid.
15 Alpha-hydroxyacids are organic carboxylic acids in which one hydroxy! group is attached to the alpha carbon adjacent the carboxy group. The generic structure is as follows:

20 where Ra and Rb are H, F, CI, Br, alkyl, aralkyl or aryl group of saturated or unsaturated, isomeric or non-isomeric, straight or branched chain or cyclic form, having 1 to 25 carbon atoms, and in addition Ra and Rb may carry OH, CHO, COOH and alkoxy groups having 1 to 9 carbon atoms. The alpha-hydroxyacids may be present as a free acid or in lactone form, or in a salt form with an organic base or an inorganic alkali. The alpha-hydroxyacids may exist as
25 stereoisomers as D, L, and Dl_ forms when Ra and Rb are not identicaL
Typical alkyl, aralkyl and aryl groups for Ra and Rb include methyl, ethyl, propyl, isopropyl, butyl, pentyl, octyl, lauryl, stearyl, benzyl and phenyl. Most preferred among the alpha-hydroxyacids are glycolic acid, iactic acid, alpha-hydroxycaprylic acid, gluconolactone and 30 combinations thereof.
Among the beta-hydroxycarboxylic acids, the most prominent and useful is salicylic acid.
Amounts of the hydroxy carboxylic acids may range from about 0.01 to about 15%, preferably 35 from about 0.1 to about 12%, more preferably from about 1 to about 8%, optimally from about 2 to about 8% by weight of the total cosmetic composition.
Humectant may be incorporated into compositions of the present invention. Humectants are normally polyols. Representative polyols include glycerin, diglycerin, polyalkylene glycols and

WO 2007/073909 PCT/EP2006/012248
more preferably alkylene polyols and their derivatives including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexytene glycol, 1,2-butylene glycol, 1,2,6-hexanetriol, isoprene glycol, 2-methyl-1,3-propanediol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. Amounts of the 5 humectant may range from about 0.01 to about 30%, preferably from about 0.1 to about 15%, optimally from about 2 to 10% by weight of the composition.
Emollients may be formulated into the compositions. These emollients may be selected from hydrocarbons, silicones, fatty alcohols, fatty acids, synthetic or natural esters and combinations 10 thereof. Amounts of the emollients may range from about 0.01 to about 30%, preferably from about 0.1 to about 10%, optimally from about 0.5 to about 5% by weight of the composition.
Hydrocarbons encompass mineral oil, polyalphaolefins and isoparaffins.
15 Among the ester emollients are:
Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms, examples of which include isoarachidyl neopentanoate, isononyl isononanoate, oleyl myristate, oleyi stearate, octyt stearate and oleyl oleate; Ether-esters such as fatty acid esters of ethoxylated fatty alcohols;
20 Polyhydric alcohol esters such as ethylene glycol mono and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl monostearate,
25 1,3-butyiene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters; Wax esters such as beeswax, spermaceti, myristyl myristate, stearyl stearate; Mono-, Di- and Triglyceride esters such as PEG-8 caprylic/capric triglyceride; and Sterols esters, of which cholesterol fatty acid esters are examples thereof.
Most preferred is glycerol monostearate available from Kessco Corporation and Sterols sold under the trademark Genera! 122®.
Natural esters which may be employed as emollients include olive oil, sunflower seed oil, 35 safflower oil, cotton seed oil, rape seed oil, palm kernel oil, palm oil and mixtures thereof.
Fatty alcohols may also serve as emollients. These are typically formed from 10 to 30 carbon atoms and include cetyl, myristyl, palmityl, stearyl, isostearyl, hydroxystearyl, oleyl, linoleyt, behenyl alcohols and mixtures thereof.

WO 2007/073909 PCIYEP2006/012248
Fatty acids having from 10 to 30 carbon atoms may also be included in the compositions of this invention. Illustrative of this category are pelargonic, lauric, myristic, palmitic, stearic, isostearic, hydroxystearic, oleic, linoleic, ricinoleic, arachidic, behenic and erucic acids. Amounts may 5 range from about 0.1 to about 20%, preferably from about 1 to about 10%, optimally from about 2 to about 5% by weight
The compositions of the present invention may comprise a skin lightening agent When used, the compositions preferably comprise from about 0.1% to about 10%, more preferably from
10 about 0.2% to about 5% by weight of the composition, of a skin lightening agent Suitable skin lightening agents include niacinamide, kojic acid, arbutin, tranexamic acid, ethyl resorcinol, placental extract, ascorbic acid and derivatives thereof (e.g. magnesium ascorbyl phosphate, sodium ascorbyl phosphate, ascorbyl glucoside, and ascorbyl tetraisopalmitates). Other skin lightening materials suitable for use herein include Actiwhite® (Cognis), Emblica® (Rona),
15 Azeloglicina (Sinerga)and extracts (e.g. mulberry extract).
Preservatives can desirably be incorporated into the cosmetic compositions of this invention to protect against the growth of potentially harmful microorganisms. Suitable traditional preservatives for compositions of this invention are alkyl esters of para-hydroxybenzoic acid.
20 Other preservatives which have more recently come into use include hydantoin derivatives, propionate satts, and a variety of quaternary ammonium compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability. Particularly preferred preservatives are phenoxyethanol, methyl para ben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate
25 and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients in the composition. Most preferred is iodopropynyl butylcarbamate available from Lonza Corporation under the trademarks Glydant Plus and Glycasil L. Preservatives are preferably employed in amounts ranging from 0.001 % to 2% by weight of the composition.
Compositions of the present invention may further include herbal extracts. Illustrative extracts include Centella Asiatica, Ginseng, Citrus Unshui, Ginko Biloba, Chamomile, Green Tea, Scullcap, Nettle Root, Swertia Japonica, Fennel and Aloe Vera extracts and combinations thereof. Amounts of each of the extracts on an actives basis may range from about 0.00001 to
35 about 1 %, preferably from about 0.001 to about 0.5%, optimally from about 0.005 to about 0.2% by weight of the composition.
Minor adjunct ingredients may also be present in the compositions. Among these may be vitamins such as vitamin E esters, vitamin C, panthenol and any of the vitamin B complexes

WO 2007/073909


(e.g. niacinamide and Vitamin B6). Retinoids may be employed induding retinol, retinyl linoleate, retinyl acetate, retinoic add and combinations thereof. Anti-irritant agents may also be present including those of steviosides, alpha-b'saboloi and glycyhrizzinate salts. Each vitamin, retinoid or anti-irritant agent may be present in amounts ranging from about 0.0001 to 5 about 1.0%, preferably from about 0.001 to about 0.5%, optimally from about 0.01 to about 0.3% by weight of the composition.
The cosmetic compositions can exhibit pH properties ranging from pH 2 to 10. A preferred embodiment has pH ranging from about 4.5 to about 7.0.
The compositions of the present invention can comprise one or more thickening agents, preferably from about 0.05% to about 10%, more preferably from about 0.1% to about 5%, and even more preferably from about 0.25% to about 4%, by weight for the composition. Non-limiting classes of thickening agents include those selected from the group consisting of:
a. Carboxylic Add Polymers
These polymers are crosslinked compounds containing one or more monomers derived from acrylic acid, substituted acrylic adds, and salts and esters of these acrylic adds and the substituted acrylic adds, wherein the crosslinking agent contains two or more carbon-carbon
20 double bonds and is derived from a polyhydric alcohol. Examples of commercially available carboxylic acid polymers useful herein include the Carbomers, which are homopotymers of acrylic add crosslinked with ally! ethers of sucrose or pentaerytritol. The Carbomers are available as the Carbopol® 900 series from Noveon Corporation (e.g. Carbopol® 954). In addition, other suitable carboxylic acid polymeric agents indude copolymers of C10-30 alkyl
25 acrylates with one or more monomers of acrytic add, methacrylic add, or one of their short chain (i.e. C1-4 alcohol) esters, wherein the crosslinking agent is an ally ether of sucrose or pentaerytriotol. These copolymers are known as Acrylates/c10-30 Alkyl Acrylate Crosspolymers and are commercially available as Carbopol® 1342, Carbopol® 1382, Ultrez® 21, Pemuien® TR-1 and Pemuien® TR-2, from Noveon Corporation.
b. Taurate Polymers
The compositions of the present invention can optionally comprise crosslinked taurate polymers useful as thickeners or gelling agents induding anionic, cationic and nonionic polymers. Examples indude hydroxyethyf acrylate/sodium acryloyldimethyi taurate (e.g. Simulgel® NS 35 and INS 100), acrylate/sodium acryloyldimethyi taurate (e.g. Simulgel® EG), Sodium acryloyldimethyi taurate (e.g. Simulgel® 800) and ammonium acryloyldimethyi taurate/vinyl pyrrolidone (e.g. Aristoflex® AVC).
c. Polyacrylamlde Polymers

WO 2007/073909


12 The compositions of the present invention can optionally comprise polyacrylamide polymers, especially nonionic polyacrylamide polymers Including substituted branched or unbrancfied polymers. Preferred among these polyacrylamide polymers is the nonionic polymer given the CTFA designation polyacrylamide and isoparaffin and laureth-7, available under the tradename 5 Sepigei© 305 from Seppic Corporation. Other polyacrylamide polymers useful herein include multi-block copolymers of acrylamides and substituted acrylamides with acrylic acids and substituted acrylic acids. Commercially available examples of these multi-block copolymers include Hypan SR150H, SS500V, SS500W and SSSA100H from Lipo Chemicals, Inc.
10 d. Polysaccharides
A wide variety of polysaccharides are useful herein. "Polysaccharides" refer to gelling agents that contain a backbone of repeating sugar (i.e. carbohydrate) units. Non-limiting examples of polysaccharide gelling agents include those selected from the group consisting of cellulose, carboxymethyl hydroxyethylcellulose, hydroxyethyicellulose, hydroxyethyl ethylcellulose,
15 hydroxypropylcellulose, hydroxypropyl methylcellulose, methyl hydroxyethylcellulose, microcrystalline cellulose, sodium cellulose sulfate and mixtures thereof.
e. Gums and Clays
Other thickening and gelling agents useful herein include materials that are primarily derived
20 from natural sources. Non-limiting examples include materials selected from the group consisting of acacia, aga, algin, alginic acid, ammonium alginate, amylopectin, calcium alginate, calcium carrageenan, carnitine, carrageenan, dextrin, gelatin, gellan gum, guar gum, guar hydroxypropyltrimonium chloride, hectorite, laponite, bentonite, hyaluronic acid, hydrated silica, hydroxypropyl chitosan, hydroxypropyl guar, karaya gum, kelp, tocust bean gum, natto gum,
25 potassium carrageenan, propylene glycol alginate, sclerotium gum, sodium carboxymethyl dextran, sodium carrageenan, tragacanth gum, xanthan gum and mixtures thereof.
Another optional ingredient may be an organic sunscreen agent. Sunscreen agents have at least one chromophoric group absorbing within the ultraviolet ranging from 290 to 400 nm.
30 Chromophoric organic sunscreen agents may be divided into the following categories (with specific examples) including: p-aminobenzoic acid, its salts and its derivatives (ethyl, tsobutyl, glyceryl esters and p-dimethylaminobenzoic acid); anthranilates (o-aminobenzoates; methyl, menthyl, phenyl, benzyl, phenylethyl, linalyt, terpinyl and cyclohexenyl esters); salicylates (octyl, amyl, phenyl, benzyl, menthyl, glyceryl and dipropylenegrycol esters); cinnamic acid derivatives
35 {menthyl and benzyl esters, alpha-phenyl cinnamonitrile and butyl cinnamoy) pyruvate); dihydroxycinnamic acid derivatives (umbelliferone, methylumbelliferone and methylaceto-umbelliferone); trihydroxycinnamic acid derivatives (esculetin, methylesculetin, daphnetin, and the glucosides, esculin and daphnin); hydrocarbons (diphenyibutadiene and sffibene); dibenzalacetone and benzalacetophenone; naphtholsulfonates (sodium salts of 2-naphthol-3,6-

WO 2007/073909


13 disulfonic and of 2-naphthol-6,B-disulfonic acids); dihydroxy-naphthoic acid and its salts; o- and p-hydroxybiphenyldisulfonates; coumarin derivatives (7-hydroxy, 7-methyi and 3-phenyl); diazoles (2-acetyl-3-bromoindazole, phenyl benzoxazole, methyl naphthoxazole and various aryl benzothiazoles); quinine salts (btsulfate, sulfate, chloride, oleate and tannate); quinoline 5 derivatives (8-hydroxyquinoIine salts and 2-phenylquinoIine); hydroxy- or methoxy-substituted benzophenones; uric and vilourlc acids; tannic acid and its derivatives (e.g. hexaethylether); (butyl carbityl) (6-propyl piperonyl) ether, hydraquinone; benzophenones (oxybenzone, sulisobenzone, dioxybenzone. benzoresorcinol, 2,2,,4,4,-tetrahydroxybenzophenone, 2,2'-dihydroxy-4,4'-dimetrioxybenzophenone and octabenzone); 4-isapropyldibenzoylmethane; 10 butylmethoxydibenzoylmethane; etocrylene; and 4-isopropyl-dibenzoylmethane.
Particularly useful are: 2-ethylhexyl p-methoxycinnamate, 4,4-t-butyl
methoxydibenzoylmethane, 2-hydroxy-4-methoxybenzophenone, octyldimethyl p-aminobenzoic
acid, digalloyltrioleate, 212-dihydroxy-4-methoxybenzophenone, ethyl 4-
15 [bisfhydroxypropyOJaminobenzoate, 2-ethylhexyJ-2-cyano-3,3-diphenylacrylateI 2-
ethylhexylsalicylate, glyceryl p-aminobenzoate, 3,3,5-trimethylcyclohexylsalicylate, methylanthranilate, p-dimethybminobenzoic acid or aminobenzoate, 2-ethylhexyl p-dimethylaminobenzoate, 2-phenylbenzimidazole-5-sulfonic add, 2-(p-dimethylaminophenyl)-5-sulfoniobenzoxazoic acid, 4-methyIbenzylidene camphor, bis-ethylhexyioxyphenol
20 methoxyphenol triazine, methylene bis-benzotriazolyl tetramethylbutylphenol, dimethicodiethylbenzal malonate, isoamyl methoxycinnamate, octyl triazone, terephthalidene dicamphor sulfonic acid and mixtures thereof. Amounts may range from about 0.1 to about 10%, preferably from about 1 to about 5% by weight of the composition.
25 Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material ought to be understood as modified by the word "abouf.
The term "comprising" is meant not to be limiting to any subsequently slated elements but 30 rather to encompass non-specified elements of major or minor functional importance, in other words the listed steps, elements or options need not be exhaustive. Whenever the words "including" or "having" are used, these terms are meant to be equivalent to "comprising" as defined above.
35 All documents referred to herein, including all patents, patent applications, and printed publications, are hereby incorporated by reference in their entirety in this disclosure. The following examples will more fully illustrate the embodiments of this invention. AH parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated.

WO 2007/073909 PCT/EP2006/012248
A series of sunscreen formulations according to the present invention are reported in these examples. The resultant creams have the following components.

Component I II III IV V
Phase A
Deionized water Qs Qs Qs Qs Qs
Phase B (Surfactant Network)
NET-WO (PEG-10 dimethicone and disteardimonium hectorite and cyclopentasiloxane) 1.8000 1.8000 1.8000 1.8000 1.8000
PEG-10 dimethicone 1.6000 1.6000 1.8000 1.8000 1.8000
Phase C (Humectant/Emollient)
Glycerin 10.0000 12.0000 12.0000 14.0000 9.0000
Caprylic/capric triglycerides 3.0000 3.0000 3.0000 3.0000 3.0000
Phase D (Sunscreen)
Titanium dioxide 6.0000 6.0000 6.0000 6.0000 6.0000
Phase E (Silicone)
DC 9045 (dimethicone crosspolymer and
cyclopentasiloxane) 26.0000 26.0000 26.0000 26.0000 26.0000
Phase F
Clarinol® A-80 (conjugated linoleic acid) 0.5000 0.5000 1.0000 1.0000 1.3000
Herbal extracts/Nutrients* 2.0000 2.0000 2.0000 2.0000 2.0000
Phase G (Fragrance/Anti-Oxidant/Preservative)
Fragrance 0.3500 0.3500 0.3500 0.3500 0.3500
Disodium EDTA 0.0500 0.0500 0.0500 0.0500 0.0500
Glydant Plus liquid (DMDM hydantoin and iodopropynyt butylcarbamate) 0.2000 0.2000 0.2000 0.2000 0.2000
Includes: vitamin E acetate, vitamin A pa Imitate, ceramide 3 and 6, bisabolol, borage oil.
coriander seed oil, sodium lactate, sodium ascorbyl phosphate, betula alba extract (white birch), DL-panthenol, sodium PCA (50%), hydrolyzed milk protein, pomegranate extract, cholesterol and stearic acid.
A series of color stability experiments were conducted to evaluate the effect of CLA in preventing discoloration upon aging of oil continuous emulsions. The following table details components of the four compositions (A-D) employed for this study.

WO 2007/073909 PCT/EP2006/012248

Composition (Weight %)
Component A B C D
Dimethicone crosspolymer
(DC 9045®) 26.00 26.00 26.00 26.00
Glycerin 10.00 10.00 10.00 10.00
Parsol MCX® (ethylhexyl methoxycinnamate) 6.00 6.00 6.00 6.00
Caprylic/capric triglycerides 3.00 3.00 3.00 3.00
Zinc Oxide or Titanium Dioxide 2.00 2.00 2.00 2.00
NET-WO (PEG-10 dimethicone and disteardimonium hectorite and cyclopentasiloxane) 1.80 1.80 1.80 1.80
PEG-10 dimethicone 0.60 0.60 0.60 0.60
TimironMP-111® 0.50 0.50 0.50 0.50
Herbal extracts and other nutrients (2) 2.08 2.08 2.08 2.08
Disodium EDTA 0.05 0.05 0.05 0.05
Glydant Plus liquid® 0.20 0.20 0.20 0.20
Conjugated linoleic acid (1) 0.00 1.00 2.00 3.00
Disodium EDTA 0.05 0.05 0.05 0.05
Glydant Plus liquid® 0.20 0.20 0.20 0.20
Water qs qs qs qs
(1) 37% c9, t11 and 38% t10, c12 linoleic acid isomer mixture.
(2) Herbal extracts/Nutrients included only in the zinc oxide formulas.
Color Comparison Test
5 Color was evaluated by the Hunter Lab method. Intrinsic optical properties of the formulas were tested using a Hunter Lab LabScan XE (Hunter Associates Laboratory, inc. Reston, Virginia) using a standard sample cup port plate. The equipment settings used were:
Spectral Performance: Wavelength Range: 400 -700nm
10 Wavelength Internal: 10nm
Bandpass: 10nm equivalent triangular Photometric Range: 0 -150%
The LabScan XE 0/45 spectrophotometer in the port-up orientation is then configured for a 15 1.75-inch area of view with UV filter set to nominal. Once the instrument is standardized following the procedure specified in the instrument manual and commercially supplied computer software, the sample is prepared for color (a*, b*. and L*) measurement.

WO 2007/073909 PCT/EP2006/012248
The black plastic ring is placed within the sample cup that is then filled with product to a level above the ring. The ceramic disk is then placed on top of the sample with the white portion facing the sample until it rests firmly on top of the plastic ring. This disk provides a white background to direct light that has traveled through the sample back to the detector. The goal 5 is to have the sample appear smooth and opaque through the bottom of the sample cup. Next, the sample is placed on the sample cup port plate and covered with the opaque cover. This cover provides a light trap to exclude interference of external light on the sample measurements. The average of three readings is used for a single color measurement representing the color of the batch. Tiie color lab is presented by the Hunter lab color space a*,
10 b*, and L*. Term a* is green-red space, term b* is blue-yellow space, and term L* is black-white space. For example, a large L* value means more white, and smaller b* value means more blue. The overall color difference from the standard sample is then determined by the value of dE*. dE* can be obtained by configuring the instrument to display it when specifying your settings or it can be calculated as follows:
The greater the value of dE, the greater the degree of color change from the control. Conversely, low values of dE indicate that the overall color of the sample is closer to that of the control.
25 Results
The resufts of the color study are reported in the tables below.
Formula with zinc oxide (results are reported for formulas held for 2 months at 43°C. Changes in the dE value are relative to the 0% CLA formula stored at 22°C for 2 months)

Sample CLA Content (%) dE Value*
A 0 0.74
B 1.0 1.21
C 2.0 2.78
D 3.0 3.63
Formula with titanium dioxide (results are reported for formulas held for 1 month at 50°C. Changes in dE value are relative to the 0% CLA formula stored at 4°C for 1 month)

WO 2007/073909 PCT/EP2006/012248

Sample CLA Content (%) dE Value*
A 0 0.654
B 1.0 0.147
C 2.0 0.163
D 3.0 0.281
In the presence of zinc oxide, addition of CLA resulted in an ever increasing color problem. By comparison, replacement of zinc oxide with titanium dioxide resulted in a stable formula, wherein CLA prevented discoloration. 5
Another property manifesting stability is that of viscosity. Sunscreen compositions with zinc oxide were compared to identical ones where titanium dioxide replaced the zinc oxide. These compositions are reported in the table at example VI. 10
"Hie compositions were placed on storage for a period of one month at 50°C. Viscosities were measured using a Brookfield RVT viscometer at 23°C, Spindles T(-B,-C or -E) at 5 rpm. Results are recorded in the tables below.
15 Formula with zinc oxide {Storage at 50°C)

Sample CLA Content (%) % Viscosity Change
1 month 2 months
A 0 33.64 38.44
B 1.0 82.48 83.97
C 2.0 318.86 342.98
D 3.0 120.14 128.24
Formula with titanium dioxide (Storage at 50°C)

Sample CLA Content (%) % Viscosity Change 1 month
A 0 -29.47
B 1.0 -27.69
C 2.0 -17.04
D 3.0 -6.51
The formulas with zinc oxide exhibited an increased viscosity change with the addition of small
20 amounts of CLA. By contrast, replacement of zinc oxide with titanium dioxide decreased
viscosity but only to a relatively small extent' As CLA increased from 1% to 3%, the viscosity

WO 2007/073909


change became less. It is evident that CLA is effective in stabilizing formulas with titanium dioxide in an oi! continuous system.

WO 2007/073909 PCT/EP2006/012248
1. A cosmetic composition which is a water-in-oil emulsion comprising:
5 (i) from 0.1 to 30% by weight of a water-in-oil emulstifying silicone surfactant;
(ii) from 0.1 to 30% by weight of a titanium dioxide sunscreen agent; and (iii) from 0.1 to 10% of a conjugated linoleic acid.
2. The composition according to claim 1 wherein the water-in-oil surfactant is a silicone
10 copolyol.
3. The composition according to claim 1 wherein the titanium dioxide is present in an
amount from 1 to 10% by weight of the composition.
15 4. The composition according to claim 1 wherein the conjugated linoleic acid is present in an amount from 1 to 3% by weight of the composition.
5. The composition according to claim 1 wherein the conjugated linoleic acid consists
essentially of at least 30% by weight of total conjugated linoleic acid present in the
20 composition of a mixture of cis-9, trans-11 and trans-10, cis-12 linoleic acids.
6. The composition according to daim 5 wherein the conjugated linoleic acid consists
essentially of at least 40% by weight of total conjugated linoleic acid present in the
composition of a mixture of cis-9, trans-11 and trans-10, cis-12 linoleic acids.
7. The composition according to claim 1 wherein the titanium dioxide has a particle size
ranging from 5 to 100 nm.
8. The composition according to claim 1 wherein the titanium dioxide has a particle size
30 ranging from 10 to 60 nm.
9. The composition according to claim 1 wherein the titanium dioxide is an oil dispersible
titanium dioxide.
Dated this 19th day of June 2008
(S. Venkatramani) Senior Patents Manager


1260-mumnp-2008 claims.doc

1260-mumnp-2008 description(complete).doc

1260-mumnp-2008 form 2.doc

1260-MUMNP-2008-ANNEXURE TO FORM 3(22-3-2012).pdf








1260-MUMNP-2008-EP DOCUMENT(19-3-2012).pdf

1260-mumnp-2008-form 1.pdf

1260-MUMNP-2008-FORM 13(19-3-2012).pdf

1260-MUMNP-2008-FORM 13(7-2-2012).pdf

1260-MUMNP-2008-FORM 18(29-9-2009).pdf

1260-mumnp-2008-form 2(tittle page).pdf

1260-mumnp-2008-form 2.pdf

1260-MUMNP-2008-FORM 3(12-8-2011).pdf

1260-MUMNP-2008-FORM 3(15-2-2011).pdf

1260-MUMNP-2008-FORM 3(15-2-2012).pdf

1260-mumnp-2008-form 3(19-6-2008).pdf

1260-MUMNP-2008-FORM 3(24-2-2010).pdf

1260-MUMNP-2008-FORM 3(4-8-2010).pdf

1260-mumnp-2008-form 3.pdf

1260-mumnp-2008-form 5.pdf

1260-MUMNP-2008-GENERAL POWER OF ATTORNEY(13-8-2010).pdf

1260-mumnp-2008-international publication report a1.pdf



1260-MUMNP-2008-PETITION UNDER RULE 137(19-3-2012).pdf

1260-MUMNP-2008-REPLY TO EXAMINATION REPORT(19-3-2012).pdf

1260-MUMNP-2008-US DOCUMENT(19-3-2012).pdf

Patent Number 252075
Indian Patent Application Number 1260/MUMNP/2008
PG Journal Number 17/2012
Publication Date 27-Apr-2012
Grant Date 24-Apr-2012
Date of Filing 19-Jun-2008
# Inventor's Name Inventor's Address
PCT International Classification Number A61K8/36
PCT International Application Number PCT/EP2006/012248
PCT International Filing date 2006-12-14
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 11/318,130 2005-12-23 U.S.A.